Intervention debulking surgery in advanced epithelial ovarian cancer
Autor: | C. W. E. Redman, David Luesley, R. Varma, George Blackledge, Jane Warwick, F. G. Lawton |
---|---|
Rok vydání: | 1994 |
Předmět: |
Adult
medicine.medical_specialty medicine.medical_treatment law.invention Randomized controlled trial law medicine Humans Prospective Studies Prospective cohort study Aged Ovarian Neoplasms Chemotherapy business.industry Ovary Hazard ratio Obstetrics and Gynecology Combination chemotherapy Middle Aged Prognosis medicine.disease Debulking Surgery Clinical trial Female Morbidity Ovarian cancer business |
Zdroj: | BJOG: An International Journal of Obstetrics and Gynaecology. 101:142-146 |
ISSN: | 1471-0528 1470-0328 |
DOI: | 10.1111/j.1471-0528.1994.tb13080.x |
Popis: | Objective: To study whether intervention debulking surgery improves survival in patients with advanced ovarian cancer who have bulky (> 2 cm) residual disease after primary surgery. Design: A prospective multicentre randomised study. Setting: Hospitals in the West Midlands. Subjects: Ovarian cancer patients with bulky residual disease after primary surgery who are considered well enough to receive cis-platinum based chemotherapy and further surgery. Methods: Eligible patients were randomised to receive combination chemotherapy alone or combined with intervention debulking surgery. Main: outcome measure Survival was assessed using product limit method and log-rank test. Results: Seventy-nine patients were entered into the study. Thirty-seven patients were randomised to intervention debulking surgery, 25 (67%) of whom underwent intervention debulking surgery, which was performed a median of 13 weeks after primary surgery. The median survival for the intervention debulking surgery group was 15 months (95% CI 10–20 mo) and that of those randomised to chemotherapy alone, which was 12 months (95% CI 8–16 mo), were not significantly different (hazard ratio = 0.71; 95% CI 0.44–1.13). Conclusion: Intervention debulking surgery may not improve survival in patients with advanced ovarian cancer. |
Databáze: | OpenAIRE |
Externí odkaz: |